Order Article Reprints

Placzke J, Rosińska M, Sobczuk P, Ziętek M, Kempa-Kamińska N, Cybulska-Stopa B, Kamińska-Winciorek G, Bal W, Mackiewicz J, Galus Ł, et al. Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report. Cancers. 2023; 15(17):4384. https://doi.org/10.3390/cancers15174384

Placzke, Joanna, Magdalena Rosińska, Paweł Sobczuk, Marcin Ziętek, Natasza Kempa-Kamińska, Bożena Cybulska-Stopa, Grażyna Kamińska-Winciorek, Wiesław Bal, Jacek Mackiewicz, Łukasz Galus, and et al. 2023. "Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report" Cancers 15, no. 17: 4384. https://doi.org/10.3390/cancers15174384

Placzke, J., Rosińska, M., Sobczuk, P., Ziętek, M., Kempa-Kamińska, N., Cybulska-Stopa, B., Kamińska-Winciorek, G., Bal, W., Mackiewicz, J., Galus, Ł., Las-Jankowska, M., Jankowski, M., Dziura, R., Drucis, K., Borkowska, A., Świtaj, T., Rogala, P., Kozak, K., Klimczak, A., ... Rutkowski, P. (2023). Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report. Cancers, 15(17), 4384. https://doi.org/10.3390/cancers15174384